Key result
TAVR yields a ~11% 10-year bioprosthetic valve failure rate in elderly patients.
Answers are grounded in this paper and cite their sources.
Editorial commentary reveals that comorbidity dictates survival after transcatheter valve replacement in elderly patients, suggesting valve durability is clinically critical only in younger cohorts.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2026) conducted an editorial in Aortic valve disease undergoing transcatheter aortic valve replacement (TAVR) (n=316). Transcatheter aortic valve replacement (TAVR) was evaluated on 10-year cumulative incidence of bioprosthetic valve failure (BVF). Transcatheter aortic valve replacement in elderly patients resulted in a 10.8% 10-year cumulative incidence of bioprosthetic valve failure and 13.8% survival.
Synapse has enriched 10 related papers. Consider them for comparative context: